world asthma foundation logo

Tag: setback

  • Glaxo and Theravance Suffer Setback – Zacks.com

    Glaxo and Theravance Suffer SetbackZacks.comIn the asthma studies, Relovair showed an encouraging efficacy profile but was associated with several side-effects, like headache, nasopharyngitis, upper respiratory tract infection, bronchitis, cough, oropharyngeal pain and influenza. …and more » View full post on asthma – Google News

  • Glaxo on the slide after trials setback for asthma drug – Evening Standard

    Reuters UK Glaxo on the slide after trials setback for asthma drugEvening StandardBut clinical trials have not shown the new treatment to be better than GSK's flagship asthma drug Advair. "The results aren't a home run but look adequate for filing and approval," said pharma analyst Emmanuel Papadakis at Collins Stewart. …GSK and Theravance Announce…